DXC's 15% Short Interest Meets a 47% Monthly Surge
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
DXC Technology heads into its October 30 earnings report with a striking contradiction: a stock that nearly halved analyst targets over summer, yet surged 47% in a month, now sitting with one of the highest short positions in its peer group.
Short sellers have not budged much. Short interest runs at 15.2% of the free float, roughly 26.5 million shares, a level that has eased about 8% from a month ago but remains firmly elevated. The ORTEX short score of 66.7 reflects that persistent bearish conviction. Yet borrow conditions tell a calmer story. Cost to borrow has eased to 0.44%, down around 12% on the week, and availability is generous at 313%, meaning lenders hold roughly three shares available for every two already out on loan. Shorts are present in size but not being squeezed. Options positioning leans constructive rather than defensive: the put/call ratio of 0.36 is nearly in line with its 20-day average and well below the 52-week high of 1.14, suggesting options traders are not rushing to hedge.
The bull and bear cases are about as wide as the valuation gap itself. Bears point to a 6.3% revenue decline in the Global Infrastructure Services segment, persistent legacy outsourcing headwinds, and a stock that rose 47% in a month without an obvious fundamental catalyst to support it. The most recent analyst consensus, struck in early August, had a mean price target around $11 to $14, well below the current $15.23 price, which means the stock has overrun the Street's own range. That cluster of August moves was mostly neutral-to-bearish: TD Cowen, Stifel and RBC all maintained hold-equivalent ratings after the prior quarter, with targets mostly in the $10 to $14 band. Bulls counter with improving book-to-bill dynamics in the GIS segment, which hit 1.28x last quarter, a 33% jump in bookings, alongside steady Insurance and BPS organic growth and $785 million of net debt reduction. On valuation, DXC trades at roughly 0.65x book and an EV/EBITDA of 3.4x, placing it in the cheapest decile of its universe by the ORTEX earnings yield factor, which ranks in the 93rd percentile.
The ownership picture adds an interesting wrinkle. BlackRock lifted its stake to 17.7% of shares, the most recent filing showing it added nearly 5 million shares in the quarter to September. American Century also added materially, lifting its position to 6.5% of shares. Against that, Glenview Capital, once holding 5.2%, disclosed that it had exited entirely by August. The Vanguard structure has reorganised across two entities but remains a top holder collectively. No Schedule 13D activist is on the register. The one prior earnings reaction on record resulted in a 4.5% one-day fall and a 5.8% decline over the following five sessions, after the July 2026 quarter print.
With the stock at $15.23 and the most recent analyst targets clustered well below that level, tonight's print is really a test of whether the improved booking momentum and debt reduction story can sustain a valuation that has already run past where the Street was willing to go just weeks ago.
Stocks in this article
See the live data behind this article on ORTEX.
Open DXC on ORTEX →How this article was generated
- Generated
- 30 Oct 2026, 04:35
- Data as of
- 30 Oct 2026, 04:04
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.